CN111529630A - Traditional Chinese medicine composition for treating thoracic obstruction syndrome - Google Patents

Traditional Chinese medicine composition for treating thoracic obstruction syndrome Download PDF

Info

Publication number
CN111529630A
CN111529630A CN202010403423.3A CN202010403423A CN111529630A CN 111529630 A CN111529630 A CN 111529630A CN 202010403423 A CN202010403423 A CN 202010403423A CN 111529630 A CN111529630 A CN 111529630A
Authority
CN
China
Prior art keywords
parts
chinese medicine
traditional chinese
medicine composition
thoracic obstruction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010403423.3A
Other languages
Chinese (zh)
Inventor
郑进
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yunnan Provincial Hospital of Traditional Chinese Medicine
Original Assignee
Yunnan Provincial Hospital of Traditional Chinese Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yunnan Provincial Hospital of Traditional Chinese Medicine filed Critical Yunnan Provincial Hospital of Traditional Chinese Medicine
Priority to CN202010403423.3A priority Critical patent/CN111529630A/en
Publication of CN111529630A publication Critical patent/CN111529630A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/898Orchidaceae (Orchid family)
    • A61K36/8988Gastrodia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/62Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine composition for treating thoracic obstruction, and belongs to the technical field of traditional Chinese medicine compositions. The composition comprises the following raw materials in parts by weight: 13-18 parts of gastrodia elata, 13-18 parts of rubia yunnanensis, 25-35 parts of astragalus membranaceus, 8-12 parts of earthworm and 13-18 parts of erigeron breviscapus. The traditional Chinese medicine composition has the effects of tonifying qi, activating blood, dredging collaterals and relieving pain; it is applicable to chest impediment type qi deficiency and blood stasis.

Description

Traditional Chinese medicine composition for treating thoracic obstruction syndrome
Technical Field
The invention relates to a traditional Chinese medicine composition for treating thoracic obstruction, belonging to the technical field of traditional Chinese medicine compositions.
Background
Chest impediment syndrome is mainly manifested as chest oppression and pain, even chest pain involving the back, shortness of breath, dyspnea and inability to lie on the back. Mild patients occasionally have a temporary and mild chest stuffiness or dull pain, or an uncomfortable feeling of paroxysmal cowy middle or vague left chest; severe cases are acutely painful, or present as crush-like colic. It is often accompanied by palpitation, shortness of breath, dyspnea, even dyspnea, panic, restlessness, pale complexion, spontaneous sweating due to cold, etc. It is induced by fatigue, satiety, coldness and emotional agitation, and can be caused by no obvious induction or rest. Chest stuffiness and pains are one of important heart system diseases threatening the life and health of middle-aged and elderly people, and the attack of the diseases tends to increase gradually along with the changes of life styles and dietary structures of modern society, so that the diseases are more and more paid attention to by people. The disease is marked by deficiency and excess of the origin, has complex clinical manifestations and pathological changes, and the traditional Chinese medicine treatment starts from the whole body and has the advantage of comprehensive action, so the disease is widely concerned.
The traditional Chinese medicine considers that the occurrence of the chest stuffiness is related to factors such as exogenous pathogenic factors invasion, improper diet, emotional disorder, aging and body weakness, and the disease nature is always deficient in origin and marked for excess. Deficiency syndrome is caused by malnutrition of heart vessels, blood circulation weakness, and blood stasis in channels and collaterals due to deficiency of heart qi, heart yin and heart yang; the excess syndrome is mainly caused by the obstruction of heart vessels by congealing cold, qi stagnation, blood stasis and phlegm turbidity, resulting in the unfavorable pulse and unsmooth blood circulation. Blood stasis is caused by the onset of chest stuffiness, so that the traditional Chinese medicine considers that the blood circulation activating and stasis removing method is the main method for treating chest stuffiness in traditional Chinese medicine. In addition, domestic research finds that the traditional Chinese medicine blood circulation promoting and blood stasis removing medicine can obviously improve the functions of heart and brain and has good effect of resisting myocardial ischemia. Yi nationality doctors believe that blood stasis toxin is a pathological product generated by blood stagnation in vivo and belongs to endogenous toxin. When blood stasis toxin obstructs heart vessels, symptoms of heart vessel obstruction such as chest pain, chest distress, palpitation and the like can be generated, and the basic treatment method for blood stasis toxin syndrome is to activate blood and remove blood stasis toxin. The existing treatment methods mainly comprise operation treatment and western medicine taking, but the western medicine taking for a long time has certain side effects, and the operation treatment not only has traumatism, but also has expensive operation cost.
Disclosure of Invention
The invention aims to provide a traditional Chinese medicine composition for treating thoracic obstruction, which comprises the following raw materials in parts by weight: 13-18 parts of gastrodia elata, 13-18 parts of rubia yunnanensis, 25-35 parts of astragalus membranaceus, 8-12 parts of earthworm and 13-18 parts of erigeron breviscapus.
Preferably, the composition of the invention comprises the following raw materials in parts by weight: 15 parts of gastrodia elata, 15 parts of rubia yunnanensis, 30 parts of astragalus membranaceus, 10 parts of earthworm and 15 parts of erigeron breviscapus.
The invention claims the principles and treatment of medicine preparation:
gastrodia elata enters liver meridian, has the functions of extinguishing wind and relieving spasm, is sweet and moist in taste, mild in medicine property, can be used for treating internal stirring of liver wind, fright epilepsy and convulsion caused by various reasons, can be used for treating dizziness and headache regardless of cold, heat, deficiency and excess, is an essential medicine for treating dizziness and headache, can also dispel external wind, dredge channels and collaterals, relieve pain, and has particularly effects on numbness of limbs, paralysis of hands and feet, rheumatic arthralgia and the like. Radix rubiae yunnanensis has the effects of promoting blood circulation, relaxing muscles and tendons, removing blood stasis, promoting tissue regeneration, and regulating qi and blood. Can be used for treating rheumatalgia, traumatic injury, dizziness, insomnia, and anemia. Radix astragali has effects of invigorating qi, consolidating superficial resistance, promoting diuresis, tonifying heart, lowering blood pressure, and enhancing capillary vessel resistance, and can be used for treating stagnation of blood due to qi and blood, and malnutrition of channels and collaterals, with symptoms of numbness of skin or hemiplegia. Earthworm, earthworm. The combination of the astragalus and the earthworm can tonify qi, promote qi and activate blood circulation, and has synergistic effect. Erigeron breviscapus has the effects of resisting blood coagulation, improving microcirculation and treating occlusive cerebrovascular diseases and cerebral hemorrhage sequelae and has better effect. The combination of the medicines has good curative effect on chest distress and pain, even chest pain involving the back, shortness of breath, inability to lie on the back and the like which are mainly manifested by thoracic obstruction.
The invention has the beneficial effects that: the traditional Chinese medicine formula disclosed by the invention has the effects of tonifying qi, activating blood circulation, dredging collaterals and relieving pain; the traditional Chinese medicine composition has a good curative effect on patients with thoracic obstruction syndrome type of qi deficiency and blood stasis, and clinical observation shows that 20 patients with thoracic obstruction syndrome have a remarkable effect, 25 patients with effective effect and 5 patients with ineffective effect, and the effect is very obvious.
Detailed Description
The present invention is further described in detail with reference to the following specific examples, but the scope of the present invention is not limited to the above description.
Example 1
A traditional Chinese medicine composition for treating thoracic obstruction syndrome comprises the following raw materials in parts by weight: 15g of gastrodia elata, 15g of rubia yunnanensis, 30g of astragalus membranaceus, 10g of earthworm and 15g of erigeron breviscapus.
Example 2
A traditional Chinese medicine composition for treating thoracic obstruction syndrome comprises the following raw materials in parts by weight: 13g of gastrodia elata, 13g of rubia yunnanensis, 25g of astragalus membranaceus, 8g of earthworm and 13g of erigeron breviscapus.
Example 3
A traditional Chinese medicine composition for treating thoracic obstruction syndrome comprises the following raw materials in parts by weight: 18g of gastrodia elata, 18g of rubia yunnanensis, 35g of astragalus membranaceus, 12g of earthworm and 18g of erigeron breviscapus.
Clinical cases: chest stuffiness 1 case. Lijialan, a woman 72 years old and 2016, the patient can see a doctor for 12 months, and the patient starts to suffer from chest pain, sudden attack and intolerance of the pain in autumn and winter before 3 years, and the pain is immediately over-suffered, and the attack occurs under the conditions of emotional agitation, fatigue or sudden fright. In the onset of chest pain, sublingual administration of nitroglycerin tablets stopped the pain. The attack is frequent in nearly half a month, the chest stuffiness lasts for about 2 minutes, the precordial region is pressed, the pain is led to the left shoulder, the pain is delayed to the neck and the back, and the symptoms of cold sweat, palpitation, short breath and insomnia are accompanied. Dark purple tongue, deep, dry and short pulse. The electrocardiogram prompts that the ST segment moves downwards and the T wave inversion completely carries out the branch conduction block of the Chinese imperial. It is diagnosed as obstruction of qi in the chest, manifested as the failure of the chest yang, qi stagnation and blood stasis. For it is indicated for chest stuffiness, promoting blood circulation, promoting qi circulation, removing blood stasis and activating blood. The formulation 5 of the present invention in example 1 was administered by decocting with water.
In the second diagnosis, chest pain is manifested as qi shortness, mental fatigue, ロ dryness, vexation, palpitation and less sleep after being taken from the upper part. The tongue is red and thready and weak. This is caused by deficiency of both qi and yin and failure of spirit to regulate the circulation of blood, so qi-tonifying, yin-nourishing and mind-tranquilizing methods are added. The composition is administered with 5 doses of the decoction.
And the third treatment, namely adding and subtracting the above formula for treating for more than a month, and checking that ST segments and T waves of the electrocardiogram are recovered to be normal obviously until chest pain is not developed.
The language of a case: in the present case, the patient is an elderly female, and the book Ling Shu & Wu evil teaches that the disease is caused by the evil in the heart. The "Su Wen & Qi Fa Hou Lun" also states that "heart disease patient is manifested as pain in chest, fullness in hypochondrium, hypochondriac pain, pain between the back and shoulder blades of the back and pain in both arms. Patients were modified to typical symptoms of thoracic obstruction: when the chest is stuffy and painful, the chest pain may cause the back to be full of pain, shortness of breath, wheezing and uneasy lying. The causes of this disease are closely related to diet disorder, emotional disorders, and physical weakness in the years. The location of the disease is in the heart, but related to the lung, liver, spleen and kidney. The first diagnosis is mainly based on the principle of principal deficiency and secondary urgency, and the disease is improved after taking the medicine, but the symptom of yin deficiency is obvious, and the qi and blood are supplemented by supplementing qi and nourishing yin on the basis of the functions of chest promoting, qi circulation, blood stasis and blood circulation. The method of promoting blood circulation by removing blood stasis is an important method for treating thoracic obstruction, but all diseases should be treated by the methods of supplementing qi, nourishing yin, relieving chest stuffiness and regulating qi on the basis of promoting blood circulation by removing blood stasis according to the specific conditions of the diseases on the premise of treatment based on syndrome differentiation. For example, in this case, in the first treatment, fructus Trichosanthis and radix Paeoniae Rubra are added, and in the second treatment, radix Ophiopogonis and fructus Schisandrae chinensis are added because of severe yin deficiency. The patient's condition needs to be closely observed and flexibly mastered to obtain better curative effect.

Claims (2)

1. A traditional Chinese medicine composition for treating thoracic obstruction syndrome is characterized in that: the composition comprises the following raw materials in parts by weight: 13-18 parts of gastrodia elata, 13-18 parts of rubia yunnanensis, 25-35 parts of astragalus membranaceus, 8-12 parts of earthworm and 13-18 parts of erigeron breviscapus.
2. The Chinese medicinal composition for treating thoracic obstruction according to claim 1, wherein: the composition comprises the following raw materials in parts by weight: 15 parts of gastrodia elata, 15 parts of rubia yunnanensis, 30 parts of astragalus membranaceus, 10 parts of earthworm and 15 parts of erigeron breviscapus.
CN202010403423.3A 2020-05-13 2020-05-13 Traditional Chinese medicine composition for treating thoracic obstruction syndrome Pending CN111529630A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010403423.3A CN111529630A (en) 2020-05-13 2020-05-13 Traditional Chinese medicine composition for treating thoracic obstruction syndrome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010403423.3A CN111529630A (en) 2020-05-13 2020-05-13 Traditional Chinese medicine composition for treating thoracic obstruction syndrome

Publications (1)

Publication Number Publication Date
CN111529630A true CN111529630A (en) 2020-08-14

Family

ID=71973891

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010403423.3A Pending CN111529630A (en) 2020-05-13 2020-05-13 Traditional Chinese medicine composition for treating thoracic obstruction syndrome

Country Status (1)

Country Link
CN (1) CN111529630A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108904713A (en) * 2018-10-08 2018-11-30 云南中医学院 A kind of Chinese medicine for treating cardiovascular disease
CN108904714A (en) * 2018-10-08 2018-11-30 云南中医学院 A kind of preparation method of Chinese medicine that treating cardiovascular disease

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108904713A (en) * 2018-10-08 2018-11-30 云南中医学院 A kind of Chinese medicine for treating cardiovascular disease
CN108904714A (en) * 2018-10-08 2018-11-30 云南中医学院 A kind of preparation method of Chinese medicine that treating cardiovascular disease

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
单顺等: "《单氏埋线经验精粹》", 30 June 2016, 中国医药科技出版社 *
国家药典委员会: "《中华人民共和国药典临床用药须知:2015年版.中药饮片卷》", 30 September 2017, 中国医药科技出版社 *
赵影: "活血通脉汤联合西药治疗老年脑梗死随机平行对照研究 ", 《实用中医内科杂志》 *

Similar Documents

Publication Publication Date Title
US20180055898A1 (en) Traditional chinese medicine composition for preventing and treating externally diabetes and a method of using the same
CN111529630A (en) Traditional Chinese medicine composition for treating thoracic obstruction syndrome
CN103893670A (en) Traditional Chinese medicine pill used for treating cardia-cerebrovascular diseases
AU2020103998A4 (en) Preparation method of Oral Liquid for the Treatment of Hypertension
CN104474197A (en) Traditional Chinese medicine wine for treating palpitation
CN103920058A (en) Traditional Chinese medicine preparation for treating headache and preparation method thereof
CN106822300B (en) Traditional Chinese medicine preparation for removing acne and beautifying face
CN103610870B (en) A kind of Chinese medicine preparation for the treatment of cardiovascular and cerebrovascular disease
CN105902872A (en) Traditional Chinese medicine composition for treating edema
CN101288767B (en) Chinese traditional medicine for control of recurrent respiratory tract infection and assisted-therapy of tumor and its preparation method
CN104147378A (en) Traditional Chinese medicine composition for treating blood-vacuity and wind-dryness type psoriasis
CN115381906B (en) Traditional Chinese medicine composition for treating metabolic syndrome and preparation method and application thereof
CN116327825B (en) A Chinese medicinal composition for treating cardiovascular diseases, and its preparation method
NL2029801B1 (en) Method for preparing jiexiang dingtong capsule for treating coronary heart disease
CN108403803B (en) Chinese medicinal compound preparation for preventing and treating cardiovascular complications of diabetes
CN105106600A (en) Composition for promoting postoperation healing of brain trauma caused by car accidents and preparing method
Jie et al. Clinical Research Progress of Fire Needle Therapy in Treating Skin Diseases
CN118512570A (en) Traditional Chinese medicine composition for treating epigastric pain, external application patch and application thereof
CN105412417A (en) Traditional Chinese medicine ointment for treating tenosynovitis and preparation method thereof
CN104825856A (en) Traditional Chinese medicinal composition for treating facial paralysis
CN111012883A (en) Traditional Chinese medicine for treating liver-kidney yin deficiency
CN107997094A (en) A kind of Ms's nourishing and health preserving soup
CN104324196A (en) Traditional Chinese medicine composition used for treating leucoderma and decoction, pill and powder thereof
CN112806572A (en) Coarse grain powder for treating coronary heart disease
CN118178564A (en) Chinese medicinal composition for treating diabetes complicated with cardiovascular and cerebrovascular diseases and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20200814